Monashee Investment Management LLC Kaleido Biosciences, Inc. Transaction History

Monashee Investment Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$5.09 - $11.07 $763,500 - $1.66 Million	-150,000 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$4.62 - $8.01 $693,000 - $1.2 Million	150,000 New	150,000 $1.12 Million
Q2 2019 Aug 07, 2019	SELL	$11.25 - $18.1 $562,500 - $905,000	-50,000 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$12.71 - $15.0 $635,500 - $750,000	50,000 New	50,000 $725,000

2.65K

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.